Robert B. Bazemore, President & CEO at Epizyme, Inc. (EPZM), sold 18,152 shares at $20.44 ($396K) on 2020-01-27, disclosed to the SEC on 2020-01-27.
Open-market sale of $396k EPZM by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.62 | 3,002 | $74K | 18.7% |
| 2 | $24.62 | 3,002 | $74K | 18.7% |
| 3 | $20.44 | 6,074 | $124K | 31.3% |
| 4 | $20.44 | 6,074 | $124K | 31.3% |
| Total | $21.82 avg | 18,152 | $396K | 100% |
| Filing → |
| EPZM | SELL | 2021-02-05 | $44K | — | Filing → |
| EPZM | SELL | 2021-01-27 | $138K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $154K | — | Filing → |